273: Back to school for biotech, Biogen's potential pivot, & Illumina's next chapter
The Readout Loud
00:00
Introduction
A discussion on the current state of the biotech industry, including topics such as Biogen's potential pivot, new leadership at Illumina, and the future of CRISPR medicine.
Play episode from 00:00
Transcript
